Advertisement
Advertisement

GRCE

GRCE logo

Grace Therapeutics, Inc. Common Stock

2.34
USD
Sponsored
+0.09
+4.00%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

2.33

-0.01
-0.64%

Grace Therapeutics, Inc. Common Stock Profile

About

Grace Therapeutics Inc. is a late-stage biopharma company advancing GTx-104, its novel injectable formulation of nimodipine which addresses high unmet medical needs for a rare disease, aneurysmal subarachnoid hemorrhage. Grace Therapeutics Inc., formerly known as Acasti Pharma Inc., is based in Princeton, New Jersey.

Info & Links

CEO

Prashant Kohli

Headquarters

103 CARNEGIE CENTER, SUITE 300
PRINCETON, NJ 08540, CANADA

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.acastipharma.com

Auditor

KPMG LLP

Share holders

32

Employees

6

Grace Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

35.98M

Enterprise Value

17.31M

Enterprise Value/EBITDA(ttm)

-1.54

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.86

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-15.58%

Return on Invested Capital(ttm)

-9.40%

Return on Assets(ttm)

-14.51%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-11.24M

Net Income Available to Common(ttm)

-5.98M

Diluted EPS(ttm)

-0.40

Share Statistics

Beta (5Y Monthly)

0.68

52-Week Change

-16.43%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

15.47M

Dividend Yield

0.00%

Float4

13.76M

% Held by Insiders

11.10%

% Held by Institutions

6.08%

Balance Sheet

Total Cash(mrq)

18.67M

Total Cash Per Share(mrq)

1.21

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

14.96%

Quick Ratio(mrq)

14.96%

Book Value Per Share(mrq)

4.19

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.42

Free Cash Flow(ytd)

-7.17M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement